A gold nanoparticle platform for the delivery of functional microRNAs into cancer cells.

Lack of affordable technologies for delivering microRNAs and siRNAs into cells on a large scale has hindered our efforts to rapidly parse through hundreds of dysregulated genes/microRNAs in order to identify drivers of complex diseases. The instability and polyanionic nature of naked microRNAs impede efficient cellular uptake and reduce half-life. Viral delivery requires cloning, microRNA mimics/inhibitors require costly modifications, and both require toxic lipofection or electroporation. To address these challenges, we developed a robust method for delivering unmodified microRNAs into cells on cysteamine-functionalized gold nanoparticles (AuNPs). We validated our method in two different tumor models and found that the best formulation of miR(1)-AuNP(10)-S-PEG(0.5) had the highest payload (10-20 fold higher than lipofection), lowest toxicity (98% of cell viability following treatment), efficient uptake (96% of cells took it), fastest endosomal escape and increased half-lives (at least 5 days) impacting cell proliferation and patterns of target gene expression.

[1]  Rui Guo,et al.  Gene delivery using dendrimer-entrapped gold nanoparticles as nonviral vectors. , 2012, Biomaterials.

[2]  Benjamin J. Raphael,et al.  Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.

[3]  C. Mirkin,et al.  Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles. , 2007, Nano letters.

[4]  Kemin Wang,et al.  Bionanotechnology based on silica nanoparticles , 2004, Medicinal research reviews.

[5]  T. Niidome,et al.  Preparation of primary amine-modified gold nanoparticles and their transfection ability into cultivated cells. , 2004, Chemical communications.

[6]  P. Gunaratne,et al.  Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. , 2010, Cancer research.

[7]  D. Bouard,et al.  Viral vectors: from virology to transgene expression , 2009, British journal of pharmacology.

[8]  Xiaowei Wang.  miRDB: a microRNA target prediction and functional annotation database with a wiki interface. , 2008, RNA.

[9]  Kevin Robbie,et al.  Nanomaterials and nanoparticles: Sources and toxicity , 2007, Biointerphases.

[10]  Rodney A. Hill,et al.  Gold nanoparticles: the importance of physiological principles to devise strategies for targeted drug delivery. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[11]  C. Ricordi,et al.  Instability of miRNA and cDNAs derivatives in RNA preparations. , 2007, Biochemical and biophysical research communications.

[12]  F. Slack,et al.  The let-7 microRNA reduces tumor growth in mouse models of lung cancer , 2008, Cell cycle.

[13]  Soo Hyun Lee,et al.  PEG conjugated VEGF siRNA for anti-angiogenic gene therapy. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[14]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[15]  Xiaowei Wang,et al.  Sequence analysis Prediction of both conserved and nonconserved microRNA targets in animals , 2007 .

[16]  Tae Gwan Park,et al.  Amine-functionalized gold nanoparticles as non-cytotoxic and efficient intracellular siRNA delivery carriers. , 2008, International journal of pharmaceutics.

[17]  J. Piñero,et al.  Apoptotic and necrotic cell death are both induced by electroporation in HL60 human promyeloid leukaemia cells , 2004, Apoptosis.

[18]  Colette McDonagh,et al.  Inhibition of Neuroblastoma Tumor Growth by Targeted Delivery of MicroRNA-34a Using Anti-Disialoganglioside GD2 Coated Nanoparticles , 2012, PloS one.

[19]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[20]  Chad A. Mirkin,et al.  Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation , 2006, Science.

[21]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[22]  R. Hartmann,et al.  MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. , 2011, Cancer research.

[23]  C. Sander,et al.  Integrated Analyses of microRNAs Demonstrate Their Widespread Influence on Gene Expression in High-Grade Serous Ovarian Carcinoma , 2012, PloS one.

[24]  K. Kelnar,et al.  Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. , 2010, Cancer research.

[25]  C. Mirkin,et al.  A fluorescence-based method for determining the surface coverage and hybridization efficiency of thiol-capped oligonucleotides bound to gold thin films and nanoparticles. , 2000, Analytical chemistry.

[26]  C. Murphy,et al.  Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. , 2005, Small.

[27]  B. Fehse,et al.  Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. , 2006, Human gene therapy.

[28]  Vincent M Rotello,et al.  Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. , 2004, Bioconjugate chemistry.

[29]  R. Shukla,et al.  Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[30]  A. Caplan,et al.  Polybrene Inhibits Human Mesenchymal Stem Cell Proliferation during Lentiviral Transduction , 2011, PloS one.

[31]  Kathryn A. O’Donnell,et al.  Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model , 2009, Cell.

[32]  A. Moursi,et al.  Comparison of Transfection Efficiency of Nonviral Gene Transfer Reagents , 2010, Molecular biotechnology.